Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
| Status: | Completed |
|---|---|
| Conditions: | Cosmetic |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 11/30/-0001 |
| Start Date: | December 2012 |
| End Date: | May 2013 |
| Contact: | Jane Lee, B.S. |
| Email: | Jlee@revance.com |
| Phone: | (510) 552-8707 |
This study will evaluate the efficacy and safety of botulinum toxin type A compared to
placebo control for the treatment of moderate to severe crow's feet lines.
Inclusion Criteria:
- Moderate to severe crow's feet lines
- Female or male, 18 to 65 years of age and in good general health
- Women of childbearing potential (WOCBP) must agree to use an effective method of
birth control during the course of the study
Exclusion Criteria:
- Any neurological condition that may place the subject at increased risk with exposure
to botulinum toxin type A
- Muscle weakness or paralysis, particularly in the area receiving study treatment
- Active skin disease or irritation at the treatment area
- Deep dermal scarring, or inability to smooth out the crow's feet lines to be treated
by manually spreading the skin apart
- Treatment with botulinum toxin type A for crow's feet lines in the last 6 months
We found this trial at
1
site
Click here to add this to my saved trials
